Companies: 10,795·Total market cap: $144.5T

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BVAXFOTCHealthcare● Active

$0.11

$-0.07(-39.61%)

Market Cap$3151385

P/E Ratio—

52W High$0.3

52W Low$0.0209

Avg Volume114K

Open$0.11

Beta1.13

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BioVaxys Technology Corp.（BVAXF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BVAXF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.24Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding19.6MShares outstanding history

Next EarningsTBAEarnings history

探索 BioVaxys Technology Corp. 数据

分析师预测—

股息不分红

盈利EPS $-0.20+64.75%

财务快照

FY 2024Revenue$0.00

202220232024

FY 2024Net Income-$4.0M▲ +48.55% YoY

202220232024

FY 2024EPS$-0.20▲ +64.75% YoY

202220232024

TTM:Revenue: $0.00Net Income: -$6.0MEPS: $-0.24View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

BioVaxys Technology Corp.

$0.11-39.61%$3.2M #2

$0.40+5.82%$8.4M #3

Bioxytran, Inc.

$0.03-1.95%$3.4M #4

Burzynski Research Institute, Inc.

$0.01+15.58%$1.4M #5

Curative Biotechnology, Inc.

$1.55-1.90%$10.6M #6

Futura Medical plc

$0.00-85.67%$1.5M

股票表现

1D-39.61%

1W-39.94%

1M+78.68%

3M+36.84%

YTD-36.15%

1Y-61.39%

5Y-93.64%

关于 BioVaxys Technology Corp.

CEOJames Christopher Passin

IPO DateDec 28, 2018

Employees3

CountryCA

Websitebiovaxys.com

BioVaxys Technology Corp. (BVAXF) is a clinical-stage biotechnology company primarily engaged in the development of innovative vaccine platforms targeting both antiviral diseases and various forms of …

Biotechnology HealthcareOTCCA

关于股票概览与关键数据

BioVaxys Technology Corp.（BVAXF）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 28, 2018 在 OTC 上市。截至最近交易日，BVAXF 股价为 $0.11，市值约为 $3.2M。过去12个月累计回报 -61.39%，年初至今回报 -36.15%。

2024 财年 BioVaxys Technology Corp. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，BioVaxys Technology Corp.（BVAXF）股价为 $0.11，在 OTC 上市，52周区间为 $0.02 – $0.30。

BVAXF 最新股价BVAXF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议